cAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-products (Q28587417)

GOA release 2020-03-11

author name string

So Motoyoshi

1

1 reference

31 January 2017

Yasuhiko Yamamoto

2

1 reference

31 January 2017

Seiichi Munesue

3

1 reference

31 January 2017

Hirobumi Igawa

4

1 reference

31 January 2017

Ai Harashima

5

1 reference

31 January 2017

Hidehito Saito

6

1 reference

31 January 2017

Dong Han

7

1 reference

31 January 2017

Takuo Watanabe

8

1 reference

31 January 2017

Hiroshi Sato

9

1 reference

31 January 2017

Hiroshi Yamamoto

Pattern recognition receptors and inflammation

10

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 October 2014

1 reference

31 January 2017

1 reference

31 January 2017

463

1 reference

31 January 2017

1

1 reference

31 January 2017

75–82

1 reference

31 January 2017

1 reference

Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression

21 April 2017

1 reference

Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105

21 April 2017

1 reference

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

21 April 2017

1 reference

S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase: IMPLICATIONS FOR ASTROCYTE DEVELOPMENT, ACTIVATION, AND TUMOR GROWTH

21 April 2017

1 reference

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Dangers within: DAMP responses to damage and cell death in kidney disease.

21 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Macrophages in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Binding of S100 proteins to RAGE: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Septic shock is associated with receptor for advanced glycation end products ligation of LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

RAGE in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Functions of S100 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Capturing adenylyl cyclases as potential drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Anti-inflammatory Agents: Present and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Induction of RAGE shedding by activation of G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Novel cAMP signalling paradigms: therapeutic implications for airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

PGE2-induced metalloproteinase-9 is essential for dendritic cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Mechanisms of soluble cytokine receptor generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

The RAGE axis in early diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084

Phosphodiesterase 4 inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140084